<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02911051</url>
  </required_header>
  <id_info>
    <org_study_id>OPM-G-H-1303</org_study_id>
    <secondary_id>2014-A01774-43-A</secondary_id>
    <nct_id>NCT02911051</nct_id>
  </id_info>
  <brief_title>Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients</brief_title>
  <official_title>Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BBraun Medical SAS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BBraun Medical SAS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The clinical study evaluates the safety of a new catheter for Urinary Intermittent
      Catheterisation in self catheterized patients
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2, 2016</start_date>
  <completion_date type="Actual">May 3, 2017</completion_date>
  <primary_completion_date type="Actual">May 3, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of Hydrolite Cath will be demonstrated by listing any adverse event(s) related to the use of Actreen® Hydrolite Cath and other occurrence</measure>
    <time_frame>All adverse event(s) occured during the 7 (±1) days, related to the use of Actreen Hydrolite Cath, will be registered.</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Intermittent Urethral Catheterization</condition>
  <arm_group>
    <arm_group_label>Actreen Hydrolite Cath</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a new hydrophilic coated catheter for Urinary Intermittent Catheterisation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Actreen Hydrolite Cath</intervention_name>
    <description>Depending of the use of the self catheterized patient could be 4 to 6 Actreen Hydrolite Cath per day</description>
    <arm_group_label>Actreen Hydrolite Cath</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. male patient

          2. patient is at least 18 years old

          3. patient having normal or impaired sensation in the urethra

          4. patient catheterizing at least 4 times a day

          5. patient using Ch 12 or 14 catheter for self clean urinary catheterization

          6. patient using a Nelaton catheter for self clean urinary catheterization

          7. patient using self clean urinary catheterization for at least one month

          8. patient covered with social insurance

        Exclusion Criteria:

          1. patient having a symptomatic urinary tract infection as assessed by the investigator
             (5 days after end of treatment for UTI, patient can be considered by the investigator
             for inclusion)

          2. patient with urethral hypersensitivity

          3. patient being mentally unstable not being assessed by the investigator as capable to
             follow the study procedure

          4. patient already participating in another clinical study or who have previously
             participated in this investigation
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chartier-Kastler Emmanuel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôspital Raymond Poincaré - Garches</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chartier-Kastler</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2016</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

